International Journal of Neuropsychopharmacology

The International Journal of Neuropsychopharmacology is a peer-reviewed journal published by Oxford University Press on behalf of the Collegium Internationale Neuro-Psychopharmacologicum (CINP), founded in 1998 and covering basic and clinical neuropsychopharmacology, with a 2025 Journal Impact Factor of 4.8《国际神经精神药理学杂志》是牛津大学出版社（OUP）代表国际神经精神药理学会（CINP）出版的同行评审期刊，1998 年创刊，涵盖基础与临床神经精神药理学，2025 年影响因子为 4.8。

Scope

• The central focus of the journal is research that advances understanding of existing and new neuropsychopharmacological agents, including their mode of action and clinical application期刊的核心焦点是推进对现有与新神经精神药理学药物认识的研究，包括其作用机制与临床应用。
• It also welcomes studies that provide insights into the biological basis of psychiatric disorders and thereby advance their pharmacological treatment期刊亦欢迎揭示精神疾病生物学基础并由此推进其药物治疗的研究。
• Research may derive from the full spectrum of biological and psychological fields of inquiry, encompassing classical and novel techniques in neuropsychopharmacology研究可源于生物学与心理学各研究领域的完整谱系，涵盖神经精神药理学的经典与新技术。
• Explicitly named strategies include neuroimaging, genetics, psychoneuroendocrinology and neuropsychology期刊明确列举的方向包括神经影像、遗传学、精神神经内分泌学与神经心理学。
• Emphasis is given to original research in the form of full-length papers and brief reports that are of wide interest and clearly advance the field期刊以具有广泛兴趣并能明确推进学科发展的原创研究为重点，形式包括全文论文与简短报告。
• Selected review articles and papers that highlight novel trends and perspectives are also considered部分综述文章以及突出新趋势与新观点的文章亦在考虑之列。

History

• The journal was officially founded in September 1997 at a meeting of the CINP Executive Committee in Vienna, under CINP president Claude de Montigny, and its first issue appeared in July 1998该刊于 1997 年 9 月在维也纳召开的国际神经精神药理学会执行委员会会议上正式决定创办，时任学会主席为（Claude de Montigny），首期于 1998 年 7 月出版。^[1]
• Bernard Lerer of the Hadassah Hebrew University Medical Center served as founding Editor-in-Chief from 1998 to 2008, supported by field editors Alan Frazer, Stephen Stahl, Lars Farde and Klaus-Peter Lesch哈达萨希伯来大学医疗中心的（Bernard Lerer）于 1998 至 2008 年任创刊主编，辅以领域编辑（Alan Frazer）、（Stephen Stahl）、（Lars Farde）与（Klaus-Peter Lesch）。
• The journal was published by Cambridge University Press until the end of 2014 and moved to Oxford University Press from volume 18 in 2015, when it also became fully open access该刊 2014 年底前由剑桥大学出版社出版，2015 年自第 18 卷起改由牛津大学出版社出版，并于同年全面开放获取。
• A fully online, paperless submission and review system was implemented in January 2005, making IJNP one of the first Cambridge University Press journals to go fully online该刊于 2005 年 1 月上线全在线无纸化投稿与评审系统，是最早全面在线化的剑桥大学出版社期刊之一。
• The 2025 Journal Impact Factor is 4.8, against 3.7 in 2024, 5.678 in 2022 and 5.176 in 2021, with a 2025 five-year impact factor of 5.3 and a CiteScore of 8.32025 年影响因子为 4.8，2024 年为 3.7，2022 年为 5.678，2021 年为 5.176，2025 年 5 年影响因子为 5.3，（CiteScore）为 8.3。
• In the 2025 Journal Citation Reports it ranks Q1 in Clinical Neurology (86.0 percentile), Q1 in Psychiatry, Q1 in Neurosciences and Q1 in Pharmacology and Pharmacy在 2025 年《期刊引证报告》中，该刊位列临床神经学 Q1（百分位 86.0）、精神病学 Q1、神经科学 Q1 与药理学与药学 Q1。

Editors

• Gregers Wegener of Aarhus University in Denmark has been Editor-in-Chief since July 2025丹麦奥胡斯大学（Aarhus University）的（Gregers Wegener）自 2025 年 7 月起任主编。
• His immediate predecessors were Anthony Grace of the University of Pittsburgh from 2020 to 2025 and Alan Frazer of UT Health San Antonio from 2008 to 2020其前任为 2020 至 2025 年任职的匹兹堡大学（Anthony Grace）与 2008 至 2020 年任职的得克萨斯大学圣安东尼奥健康科学中心（Alan Frazer）。
• Deputy editors are Kostas Fountoulakis of Thessaloniki, Greece, and Tsuyoshi Miyakawa of Toyoake, Japan, with Livea Dornela Godoy of Brazil as editorial manager副编辑为希腊塞萨洛尼基的（Kostas Fountoulakis）与日本丰田町的（Tsuyoshi Miyakawa），巴西的（Livea Dornela Godoy）任编辑经理。
• Field editors cover clinical neuropsychopharmacology, preclinical neuropsychopharmacology and neuroimaging, among them Joshua Kantrowitz of Columbia University and Romina Mizrahi of McGill University领域编辑覆盖临床神经精神药理学、前临床神经精神药理学与神经影像，包括哥伦比亚大学的（Joshua Kantrowitz）与麦吉尔大学的（Romina Mizrahi）。
• The editorial board numbers about 50 members drawn from more than ten countries across Europe, the Americas, Asia and Australia编委会约有 50 位成员，来自欧洲、美洲、亚洲与澳大利亚的十余个国家。
• The journal publishes twelve issues a year, its median time from submission to first decision was 22.5 days in 2025, and CINP members receive a 30% discount on the open access fee该刊每年出版 12 期，2025 年投稿至首次决定的中位时间为 22.5 天，（CINP）会员可享 30% 的开放获取费减免。